In addition to decreased metabolism of glucose by cancer cells and enhanced function of NK cells, PBP-priming might also alter the obese tissue microenvironment by blocking prohibitin on adipocytes; adipocytes, as well as melanoma cells, express sufficient prohibitin to render them targets for PBP binding. The gene discussed is PHB1; the disease is cancer.